VKH
ATNM icon

Virtu KCG Holdings’s Actinium Pharmaceuticals ATNM Stock Holding History

Virtu KCG Holdings’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$540K Buy
14,765
+13,369
+958% +$559K 0.02% 1067
2017
Q1 		$63K Buy
1,396
+945
+210% +$36.3K ﹤0.01% 2790
2016
Q4 		$12K Sell
451
-3,123
-87% -$97.7K ﹤0.01% 3273
2016
Q3 		$145K Buy
+3,574
New +$183K ﹤0.01% 2511
2016
Q2 		– Sell
-847
Closed -$51K – 2932
2016
Q1 		$51K Buy
+847
New +$53.5K ﹤0.01% 2455
2015
Q4 		– Sell
-1,759
Closed -$93K – 3473
2015
Q3 		$93K Buy
1,759
+389
+28% +$26K ﹤0.01% 2849
2015
Q2 		$109K Buy
1,370
+311
+29% +$26.5K ﹤0.01% 2877
2015
Q1 		$78K Sell
1,059
-1,881
-64% -$224K ﹤0.01% 2710
2014
Q4 		$520K Buy
2,940
+2,585
+728% +$491K 0.01% 1642
2014
Q3 		$71K Buy
+355
New +$70.4K ﹤0.01% 3266

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return

Virtu KCG Holdings's ATNM Position: Q2 2017 in Review

Virtu KCG Holdings increased its Actinium Pharmaceuticals (ATNM) stake by 958% in Q2 2017, buying an estimated $559K and bringing the position to 14,765 shares worth $540K. The position accounts for 0.02% of the portfolio, ranked #1067.

Virtu KCG Holdings first reported a position in ATNM in Q3 2014 and has held it in 10 quarters since. 26 funds tracked by Wall St. Rank hold ATNM as of Q2 2017.

  • Virtu KCG Holdings held 14,765 shares of Actinium Pharmaceuticals worth $540K as of Q2 2017.
  • Virtu KCG Holdings bought 13,369 Actinium Pharmaceuticals shares in Q2 2017, an estimated $559K.
  • Actinium Pharmaceuticals made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #1067 holding.
  • Virtu KCG Holdings first reported a position in Actinium Pharmaceuticals in Q3 2014 and has held it in 10 quarters since.
  • 26 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.